AA
41
-4
EL
30
-3
CMS
67
3
LEN
55
-9
HAS
55
-2
KSS
39
6
PCG
80
3
HOG
50
6
AN
50
-5
EXC
53
6
SWK
81
-3
CA
36
-4
IVZ
50
-3
EXPD
53
-3
RSG
59
2
C
60
-2
MDLZ
65
-2
MSI
72
2
GM
58
-2
DHI
53
-3
AA
41
-4
EL
30
-3
CMS
67
3
LEN
55
-9
HAS
55
-2
KSS
39
6
PCG
80
3
HOG
50
6
AN
50
-5
EXC
53
6
SWK
81
-3
CA
36
-4
IVZ
50
-3
EXPD
53
-3
RSG
59
2
C
60
-2
MDLZ
65
-2
MSI
72
2
GM
58
-2
DHI
53
-3
Financhill
Back

Veracyte Vs. ProPhase Labs Industry Stock Comparison

Buy
79

VCYT
Veracyte

Last Price:
34.87
Seasonality Move:
5.84%
Sell
29

PRPH
ProPhase Labs

Last Price:
2.34
Seasonality Move:
18.18%
Buy
79
Veracyte (VCYT) is a Buy

Is Veracyte a Buy, Sell or Hold?

  • The current Veracyte [VCYT] share price is $34.86. The Score for VCYT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $2.34. The Score for PRPH is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCYT Stock Price Chart

What is Veracyte's stock price today?

  • The Veracyte share price today is $34.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCYT is experiencing slight buying pressure.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $2.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight selling pressure.

VCYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.54 Buy
Relative Strength Index (14 RSI): 67.64 Buy
Chaikin Money Flow: 92085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30 - 33.48) Buy
Bollinger Bands (100): (20.37 - 29.65) Buy

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 40.85 Sell
Chaikin Money Flow: -30930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.77) Sell
Bollinger Bands (100): (2.65 - 4.77) Sell

VCYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.19 Buy
20-day SMA: 31.7 Buy
50-day SMA: 28.51 Buy
200-day SMA: 24.5 Buy
8-day EMA: 33.45 Buy
20-day EMA: 31.88 Buy
50-day EMA: 29.15 Buy
200-day EMA: 25.24 Buy

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.49 Sell
20-day SMA: 2.54 Sell
50-day SMA: 2.76 Sell
200-day SMA: 4.45 Sell
8-day EMA: 2.48 Sell
20-day EMA: 2.56 Sell
50-day EMA: 2.9 Sell
200-day EMA: 4.25 Sell

Veracyte Earnings Growth & VCYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.05 per share, an increase this year of $0.92 per share, and an increase next year of $0.15 per share.

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.38 per share, and an increase next year of $0.32 per share.

Veracyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):